HLA-C and neoplasm: Transforming growth factor β affects dcs in numerous ways that negatively affect their ability to prime tumour-specific T cells, including downregulation of cell-surface major histocompatibility complex (mhc) antigens, downregulation of co-stimulatory molecules and chemokine receptors, and impairment of maturation and migration to secondary lymphoid organs.